AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Why a gluten-free diet fails in some coeliac patients

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like...

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...

TGA approves donanemab for treatment of early Alzheimer's

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...

Content from other channels on our network

Head to toe: operating room workwear essentials

Immediate action needed for private hospital sector

NSW reforms to see trained GPs treat and diagnose ADHD

Raising 'tech neck' awareness this Spinal Health Week

Queensland Health faces alleged racial discrimination

Swinburne scientists turn cereal waste into wound dressing

Australian landfills near breaking point

Deakin and Country Road create high-value fine Merino yarn

WaterAid Australia launches Walk for Water 2025

Sydney Water removes 300,000 kg of stormwater pollution

South32 to explore emission reductions in alumina refining

Using AI to trace the origins of 3D-printed parts

Coca-Cola unveils its largest canning line in Brisbane

Australia–Japan partnership showing a path to hydrogen leadership

CeMAT 2025 incorporates processing, packaging and more